| Drug Name: | Zaleplon (151319-34-5) |
|---|---|
| PubChem ID: | 5719 |
| SMILES: | CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C |
| InchiKey: | HUNXMJYCHXQEGX-UHFFFAOYSA-N |
| Therapeutic Category: | Anticonvulsants, Central Nervous System Agents, Central Nervous System Depressants, GABA Agents, GABA Modulators, Hypnotics and Sedatives, Neurotransmitter Agents |
| Molecular Weight (dalton) | : | 305.341 |
| LogP | : | 2.64078 |
| Ring Count | : | 3 |
| Hydrogen Bond Acceptor Count | : | 5 |
| Hydrogen Bond Donor Count | : | 0 |
| Total Polar Surface Area | : | 74.29 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category